Take­da shut­ter­ing Chica­go com­plex with 1,000 staffers in lead-up to Shire merg­er

The for­mal deal to merge Take­da and Shire in­to one com­pa­ny has yet to be closed, but the Japan­ese bio­phar­ma is al­ready bring­ing the ax down hard on its US group.

Take­da an­nounced to­day that it is shut­ter­ing its op­er­a­tions near Chica­go, slam­ming the door on 1,000 jobs as they con­cen­trate their forces in the Boston area.

“The work cur­rent­ly per­formed at Take­da’s Deer­field lo­ca­tion will pro­gres­sive­ly con­sol­i­date from Deer­field in­to the greater Boston area fol­low­ing a suc­cess­ful clos­ing of the Shire ac­qui­si­tion (which is sub­ject to share­hold­er ap­provals and reg­u­la­to­ry con­sents),” a spokesper­son told re­porters. “This move, while dif­fi­cult, will al­low clos­er col­lab­o­ra­tion across Take­da to best po­si­tion our fu­ture pipeline for suc­cess. It will al­so sim­pli­fy our ex­ist­ing Take­da U.S op­er­a­tions.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER